Hepatocyte-directed MR contrast agents: Can we take advantage of bile acids?

Acta Radiologica, Supplement

Volumn 38, Issue 412, 1997, Pages 125-133

  Anelli, P L ^a   Calabi, L ^a   De Haen C ^a   Lattuada, L ^a   Lorusso, V ^a   Maiocchi, A ^a   Morosini, P ^a   Uggeri, F ^a  

^a Bracco SpA   (Italy)

Author keywords

Bile acids; Gadolinium conjugates, experimental; Hepatocyte directed; MR imaging, contrast media; Organ directed

Indexed keywords

BILE ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG CARRIER; GADOLINIUM;

ANIMAL; ARTICLE; BILE; CHEMISTRY; DRUG DESIGN; HISTOLOGY; HUMAN; LIVER; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TIME;

ANIMALS; BILE; BILE ACIDS AND SALTS; CONTRAST MEDIA; DRUG CARRIERS; DRUG DESIGN; GADOLINIUM; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 0030626371     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ALDINI R., RODA A., MORSELLI LABATE A. M. et al.: Hepatic bile acid uptake. Effect of conjugation, hydroxyl and keto groups, and albumin binding. J. Lipid Res. 23 (1982), 1167.
2. ANELLI P. L., BELTRAMI A., LOLLI M. & UGGERI F.: One-pot alkoxymercuriation-bromodemercuriation. A versatile access to 3-alkoxy-2-bromopropanoic esters. Synth. Commun. 23 (1993), 2639.
3. ANELLI P. L., CALABI L., DE HAEN C. et al.: A new approach to hepatospecific MRI contrast agents. Gadolinium complexes conjugated to iodinated synthons. Gazz. Chim. Ital. 126 (1996), 89.
4. ANELLI P. L., DE HAËN C., FEDELI F., MURRU M. & UGGERI F.: New targeted MRI contrast agents. In: New developments in contrast agent research, p. 29. Edited by P. A. Rinck & M. N. Muller. Proc. 4th Special Topic Semin., Eur. Magn. Reson. Forum, Santiago de Compostela 1994.
5. BETEBENNER D. A., CARNEY P. L., ZIMMER A. M. et al.: Hepatobiliary delivery of polyaminopolycarboxylate chelates. Synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium-111 chelate. Bioconjugate Chem. 2 (1991), 117.
6. DE HAEN C. & GOZZINI L.: Soluble-type hepatobiliary contrast agents for MR imaging. J. Magn. Reson. Imaging 3 (1993), 179.
7. DE HAËN C., LORUSSO V., LUZZANI F. & TIRONE P.: Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. Acad. Radiol. 2 (1995), 232.
8. VON DIPPE P. & LEVY D.: Expression of the bile acid transport protein during liver development and in the hepatoma cells. J. Biol. Chem. 265 (1990), 5942.
9. HILTON M. L., JONES A. S. & WESTWOOD J. R. B.: The synthesis and antibacterial activity of some basic derivatives of the bile acids. J. Chem. Soc. (1955), 3449.
10. HOFFMAN N. E., ISER J. H. & SMALLWOOD R. A.: Hepatic bile acid transport. Effect of conjugation and position of the hydroxyl groups. Am. J. Physiol. 229 (1975), 298.
11. KRAMER W., WESS G., ENHSEN A. et al.: Bile acid derived HMG-CoA reductase inhibitors. Biochim. Biophys. Acta 1227 (1994), 137.
12. KRAMER W., WESS G., SCHUBERT G. et al.: Liver-specific drug targeting by coupling to bile acids. J. Biol. Chem. 267 (1992), 18598.
13. MEIER P.: Biliary excretion of bile acids. In: Progress in pharmacology and clinical pharmacology, vol 8/4, p. 159. Biliary excretion of drugs and other chemicals. Edited by C. P. Sieger & J. B. Watkins III. Gustav Fischer Verlag, Stuttgart 1991.
14. OKAHATA Y., ANDO R. & KUNITAKE T.: Catalytic hydrolysis of p-nitrophenyl esters in the presence of representative ammonium aggregates. Specific activation of a cholesteryl nucleophile bound to a dialkylammonium bilayer membrane. Bull. Chem. Soc. Jpn. 52 (1979), 3647.
15. SCHUHMANN-GIAMPIERI G., SCHMITT-WILLICH H., PRESS W.-R., WEINMANN H.-J. & SPECK U.: Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183 (1992), 59.